Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

142.72 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
AbbVie To Submit European Application For Epcoritamab In Lymphoma Setting Later In 2022
 
Via Benzinga
Best Stocks for 2022: After Two Quarters, Who Holds The Lead?
After the first two quarters of fiscal year 2022, who holds the top spot in the InvestorPlace Best Stocks for 2022 contest? Let's dive in. 
Via InvestorPlace
Dow Jones Giant UnitedHealth Breaks Out, Leading 5 Stocks To Watch
UNH stock and AbbVie boast favorable tailwinds, including the market's defensive tilt. 
Via Investor's Business Daily
Peering Into AbbVie's Recent Short Interest
AbbVie's (NYSE:ABBV) short percent of float has risen 6.52% since its last report. The company recently reported that it has 14.42 million shares sold short, which is 0.98% of all... 
Via Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
AbbVie Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 10 strange trades. 
Via Benzinga
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
 
Via Benzinga
AbbVie Stock’s Healthy Yield Makes it a High-Conviction Holding
Between the dividend payouts and the potential price appreciation, ABBV stock could be a pharma-market winner in 2022. 
Via InvestorPlace
7 Safe Dividends Stocks to Buy in July
Here're seven safe dividend stock to buy now. BKH, ITW, NDSN, SYY, and UVV can make great investments in July. 
Via InvestorPlace
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 6.62% on an annualized basis producing an average annual return of 16.0%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
7 Overlooked Blue-Chip Stocks to Add to Your Buy List
With investors seeking viable ideas during this strange time, overlooked blue-chip stocks to buy could offer stable contrarian upside. 
Via InvestorPlace
Top Millennial, Gen Z Stocks Shift To Energy Plays; Popular Pick Tesla Poised To Open U.S. Supercharger Network To Others
Younger adults are investing earlier than prior generations. What are their top picks? 
Via Investor's Business Daily
What 7 Analyst Ratings Have To Say About AbbVie
Over the past 3 months, 7 analysts have published their opinion on AbbVie (NYSE:ABBV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
How To Make Money In This Bear Market
To the astute and disciplined value investor, bear markets bring opportunity, and more to the point, safety. 
Via Talk Markets
Is AbbVie Stock A Buy As Humira Biosimilar Rivals Loom?
Is AbbVie stock a buy today with its biggest medicine, Humira, soon to face biosimilar rivals in the U.S.? Is AbbVie stock a buy today 
Via Investor's Business Daily
Benzinga Before The Bell: Elon Musk's Kids, Apple's Potential Security Measure, Covid-19 Vaccine Wastage And Other Top Financial Stories Thursday, July 7
CNBC 
Via Benzinga
Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills
Provisions in the 2017 Republican tax law allow AbbVie Inc (NYSE: ABBV) to generate most of its sales in the U.S. while reporting virtually no income in the U.S. for tax purposes. 
Via Benzinga
Best Stocks for 2022: AbbVie Is a Recession-Resistant Dividend King
ABBV stock is one of the best choices you can make for 2022. Even though the company is losing its Humira patent soon, it isn't slowing down. 
Via InvestorPlace
Applied Molecular Shares Tumble After Disappointing Data From Mid-Stage Ulcerative Colitis Study
Applied Molecular Transport Inc (NASDAQ: AMTI) has 
Via Benzinga
7 Dividend Stocks to Buy in July 2022
Dividend stocks are only becoming more attractive as income becomes increasingly paramount. These seven equities pair dividends with safety. 
Via InvestorPlace
Check Out What Whales Are Doing With ABBV
Someone with a lot of money to spend has taken a bullish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Analyzing AbbVie's Short Interest
AbbVie's (NYSE:ABBV) short percent of float has risen 27.78% since its last report. The company recently reported that it has 13.52 million shares sold short, which is 0.92%... 
Via Benzinga
Top 3 Dividend Stocks For Any Market
As inflation heats up and the Fed raises interest rates, now is the time to check out AbbVie, Enterprise Product Partners, and NextEra Energy Partners. 
Via Talk Markets
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 6.01% on an annualized basis producing an average annual return of 15.88%. Currently, AbbVie has a market capitalization of... 
Via Benzinga
AbbVie Whale Trades Spotted
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid... 
Via Benzinga
Why AbbVie Stock Is Trading Higher Today
AbbVie Inc (NYSE: ABBV) shares are trading higher Tuesday after the company announced it submitted a supplemental New Drug Application for atogepant to the U.S. Food and Drug Administration to support... 
Via Benzinga
Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money
With an economic hurricane on the horizon, investors are searching for alternative investment paths and profitable places to invest in. 
Via InvestorPlace
Jim Cramer Says This Is A Terrific Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rapid7, Inc. (NASDAQ: RPD) doesn’t make money, so he will not go for it. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.